These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25226793)

  • 1. Novel tactics for designing water-soluble molecules in drug discovery.
    Walker MA
    Expert Opin Drug Discov; 2014 Dec; 9(12):1421-33. PubMed ID: 25226793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity.
    Hill AP; Young RJ
    Drug Discov Today; 2010 Aug; 15(15-16):648-55. PubMed ID: 20570751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
    Meanwell NA
    Chem Res Toxicol; 2011 Sep; 24(9):1420-56. PubMed ID: 21790149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement.
    Murdande SB; Pikal MJ; Shanker RM; Bogner RH
    Pharm Dev Technol; 2011 Jun; 16(3):187-200. PubMed ID: 20429826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low solubility in drug development: de-convoluting the relative importance of solvation and crystal packing.
    Docherty R; Pencheva K; Abramov YA
    J Pharm Pharmacol; 2015 Jun; 67(6):847-56. PubMed ID: 25880016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of lipophilicity in drug discovery and design.
    Arnott JA; Planey SL
    Expert Opin Drug Discov; 2012 Oct; 7(10):863-75. PubMed ID: 22992175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in aqueous solubility achieved via small molecular changes.
    Walker MA
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5100-5108. PubMed ID: 29100802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calculation of aqueous solubility of crystalline un-ionized organic chemicals and drugs based on structural similarity and physicochemical descriptors.
    Raevsky OA; Grigor'ev VY; Polianczyk DE; Raevskaja OE; Dearden JC
    J Chem Inf Model; 2014 Feb; 54(2):683-91. PubMed ID: 24456022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of aqueous solubility from SCRATCH.
    Jain P; Yalkowsky SH
    Int J Pharm; 2010 Jan; 385(1-2):1-5. PubMed ID: 19819319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical cocrystals and poorly soluble drugs.
    Thakuria R; Delori A; Jones W; Lipert MP; Roy L; Rodríguez-Hornedo N
    Int J Pharm; 2013 Aug; 453(1):101-25. PubMed ID: 23207015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An interesting relationship between drug absorption and melting point.
    Chu KA; Yalkowsky SH
    Int J Pharm; 2009 May; 373(1-2):24-40. PubMed ID: 19429285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances on aqueous solubility prediction.
    Wang J; Hou T
    Comb Chem High Throughput Screen; 2011 Jun; 14(5):328-38. PubMed ID: 21470182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aqueous solubility: simple predictive methods (in silico, in vitro and bio-relevant approaches).
    Elder D; Holm R
    Int J Pharm; 2013 Aug; 453(1):3-11. PubMed ID: 23124107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry.
    Ishikawa M; Hashimoto Y
    J Med Chem; 2011 Mar; 54(6):1539-54. PubMed ID: 21344906
    [No Abstract]   [Full Text] [Related]  

  • 15. Physicochemical properties of water and its effect on drug delivery. A commentary.
    Loftsson T; Brewster ME
    Int J Pharm; 2008 Apr; 354(1-2):248-54. PubMed ID: 17920796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A computational model for the prediction of aqueous solubility that includes crystal packing, intrinsic solubility, and ionization effects.
    Johnson SR; Chen XQ; Murphy D; Gudmundsson O
    Mol Pharm; 2007; 4(4):513-23. PubMed ID: 17539661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
    Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
    Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral formulation strategies to improve solubility of poorly water-soluble drugs.
    Singh A; Worku ZA; Van den Mooter G
    Expert Opin Drug Deliv; 2011 Oct; 8(10):1361-78. PubMed ID: 21810062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
    Bikiaris DN
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1501-19. PubMed ID: 21919807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound selection for development - is salt formation the ultimate answer? Experiences with an extended concept of the "100mg approach".
    Korn C; Balbach S
    Eur J Pharm Sci; 2014 Jun; 57():257-63. PubMed ID: 24036162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.